Form 4: Prestige Consumer Healthcare Executive Mekhail Adel Reports Stock Transactions

EVP of Marketing & Sales at Prestige Consumer Healthcare, Mekhail Adel, reports acquisition and disposal of company stock following the vesting of performance stock units.

Summary

• On May 6, 2024, Mekhail Adel, EVP of Marketing & Sales at Prestige Consumer Healthcare Inc., reported transactions involving the company's common stock.
• Adel acquired 5,472 shares of common stock at $0, representing the settlement of performance stock units (PSUs) granted on May 3, 2021, which vested on May 6, 2024.
• These PSUs vested based on the achievement of goals related to adjusted earnings per share growth.
• Concurrently, Adel disposed of 3,303 shares at a price of $70 per share.
• Following these transactions, Adel directly owns 18,843 shares of Prestige Consumer Healthcare Inc.
• The report was filed on May 8, 2024.

Sentiment

Score: 6

Explanation: The document is a routine filing of stock transactions by a company executive. The vesting of PSUs suggests the company met certain performance goals, which is mildly positive.

Positives

• The vesting of performance stock units indicates that the company achieved its adjusted earnings per share growth goals.

Industry Context

Form 4 filings are standard practice for company insiders to report changes in their beneficial ownership of company stock, providing transparency to investors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.

Key Dates